April 2026 in “Clinical and Experimental Dermatology” Alopecia areata (AA) presents a complex burden that includes significant psychosocial distress influenced by personal perceptions and stigma, rather than just the severity of hair loss. Effective treatment should prioritize patient-reported outcomes like psychological wellbeing and social functioning, not just hair regrowth. Although JAK inhibitors have enhanced clinical and quality-of-life outcomes, disparities in access to treatments and support services hinder optimal care. The financial burden of AA is substantial and often overlooked, highlighting the need for equitable healthcare policies and cost-effective treatment strategies.
November 2010 in “Value in Health” Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.
1 citations
,
August 2025 Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.
7 citations
,
February 2023 in “Exploration of Medicine” Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.
40 citations
,
September 2024 in “Heliyon” Nanobioceramics can effectively and cheaply heal wounds without side effects.